Detalles de la búsqueda
1.
Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapyâ.
Ann Oncol
; 32(4): 500-511, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33418062
2.
Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study).
Ann Oncol
; 32(1): 49-57, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33098995
3.
Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial.
Ann Oncol
; 28(3): 497-504, 2017 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27831502
4.
BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial.
Breast Cancer Res Treat
; 166(3): 775-785, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28822007
5.
Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study.
Ann Oncol
; 27(11): 2053-2059, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27502721
6.
Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial.
Br J Cancer
; 107(6): 956-60, 2012 Sep 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-22892393
7.
Systematic analysis of parameters predicting pathological axillary status (ypN0 vs. ypN+) in patients with breast cancer converting from cN+ to ycN0 through primary systemic therapy (PST).
Clin Exp Metastasis
; 35(8): 777-783, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30324492
8.
Induction of telomerase activity in stimulated human lymphocytes precedes expression of topoisomerase II alpha.
Ann Hematol
; 76(3-4): 111-5, 1998.
Artículo
en Inglés
| MEDLINE | ID: mdl-9619727
Resultados
1 -
8
de 8
1
Próxima >
>>